CNO Financial Group

CNO Financial Group, Inc. is an insurance holding company, which engages in developing, marketing, and administering health insurance, annuity, individual life insurance and other insurance products. It operates through the following segments: Bankers Life, Washington National, and Colonial Penn. The Bankers Life segment markets and distributes medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based sales offices. The Washington National segment markets and distributes supplemental health including specified disease, accident and hospital indemnity insurance products and life insurance to middle-income consumers at home and at the worksite. The Colonial Penn segment markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the Internet and telemarketing. The company was founded in 1979 and is headquartered in Carmel, IN.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

CNO Financial Group reports solid Q1 performance amidst challenges

CNO Financial Group's Q1 2023 performance showcased strengths in sales growth and agent recruiting, but challenges were evident in net income and the Med Supp block. Despite this, opportunities exist in insurance product margin growth and commercial mortgage market developments.

CNO Financial Group reports robust Q3 performance and eyes expansion

CNO Financial Group delivered a strong performance in Q3 2023, driven by robust sales momentum and increased operating earnings. While challenges related to market uncertainties and the impact of specific medications exist, the company's unchanged outlook and strategic initiatives position it for continued growth and expansion.

CNO Financial Group reports strong Q4 earnings and outlines growth opportunities for 2024

CNO Financial Group's Q4 2023 earnings call highlighted strong performance, with notable growth in premium and sales across divisions. While the company faces challenges related to improving ROE and managing healthcare events, its focus on expanding earnings and driving profitable growth presents promising opportunities for the future.

CNO Financial Group excels in Q1 2024, eyes growth opportunities

CNO Financial Group's Q1 2024 earnings call highlighted strong performance across its Consumer and Worksite businesses, supported by a focus on sustainable growth and operational efficiency. The company is maintaining full-year guidance and is actively addressing challenges related to ROE and distribution risk. Opportunities for growth through acquisitions and investment strategies are being pursued.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARMEL, Ind., July 20, 2020 /PRNewswire/ -- CNO Financial Group, Inc.

CNO Financial Group Announces Second Quarter 2020 Earnings Release Date

Algonquin Power & Utilities

Alexandria Real Estate Equities

American Water Works

Cogent Communications Holdings

Kroger

Newmont Mining

Northrop Grumman

Pembina Pipeline

Power Integrations

Shoe Carnival

Tetra Tech

UnitedHealth Group

Werner Enterprises

Watsco

This article provides a summary of dividend changes in Q2 2020.

Summary Of Dividend Changes In Q2 2020

Let's see if CNO Financial Group (CNO) stock is a good choice for value-oriented investors right now from multiple angles.

Should Value Investors Choose CNO Financial (CNO) Stock Now?

EverBank Financial

Horace Mann Educators

MGIC Investment

Old Republic International

Bright Near-Term Outlook for Multiline Insurance Industry

CNO (CNO) reported earnings 30 days ago. What's next for the stock?

Why Is CNO (CNO) Up 21.4% Since Last Earnings Report?

CARMEL, Ind., June 2, 2020 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) today announced the appointment of Chief Actuary Karen DeToro as its chief risk officer (CRO), effective June 15, 2020. DeToro will continue to serve as chief actuary in addition to her appointment as chief...

CNO Financial Group Chief Actuary Karen DeToro Named Chief Risk Officer

Riding high on its cost-curbing initiatives and solid first-quarter results, CNO Financial (CNO) holds enough potential to reap benefits for investors.

Why Should You Hold CNO Financial (CNO) in Your Portfolio?

CNO Financial's (CNO) CEO Gary Bhojwani on Q1 2020 Results - Earnings Call Transcript

CNO Financial's (CNO) Q1 results reflect lower expenses and growth in health and life production.

CNO Financial's (CNO) Q1 Earnings Beat Estimates, Surge Y/Y

CNO (CNO) delivered earnings and revenue surprises of 45.00% and -24.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CNO Financial (CNO) Q1 Earnings Surpass Estimates

CNO Financial (CNO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy CNO Financial (CNO) Ahead of Earnings?

CNO (CNO) Down 29.6% Since Last Earnings Report: Can It Rebound?

CNO Financial Group's (CNO) CEO Gary Bhojwani on Q4 2019 Results - Earnings Call Transcript

CNO Financial's (CNO) fourth-quarter results gain traction from better revenues.

CNO Financial's (CNO) Q4 Earnings Beat Estimates, Surge Y/Y

Arch Capital

Assurant

Allstate

Players in the insurance industry are likely to have gained from increase in rate hikes and effect of share buyback, partly offset by catastrophe losses.

Insurance Stock Earnings Roster for Feb 11: AIZ, ACGL, CNO

Riding high on its growing top line, reducing costs and an impressive capital position, CNO Financial (CNO) is well placed to benefit its investors.

Why is Hold Strategy Appropriate for CNO Financial (CNO) Now?

Why Is CNO (CNO) Up 3.4% Since Last Earnings Report?

CNO Financial Group, Inc. (CNO) CEO Gary Bhojwani on Q3 2019 Results - Earnings Call Transcript

CNO Financial's (CNO) third-quarter results reflect lower revenues.

CNO Financial's (CNO) Q3 Earnings Lag Estimates, Fall Y/Y

Riding high on its strong revenue base and a solid capital position, CNO Financial (CNO) is expected to reap benefits for investors.

Why Should You Retain CNO Financial (CNO) in Your Portfolio?

Why Is CNO (CNO) Down 15.6% Since Last Earnings Report?

CNO Financial Group's (CNO) CEO Gary Bhojwani on Q2 2019 Results - Earnings Call Transcript

CNO Financial's (CNO) second-quarter earnings match estimates but slip year over year due to soft revenues.

CNO Financial's (CNO) Q2 Earnings Meet Estimates, Fall Y/Y

CNO (CNO) delivered earnings and revenue surprises of 0.00% and 6.84%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CNO Financial (CNO) Meets Q2 Earnings Estimates

CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for CNO Financial Group Stock (CNO)